Form 8-K - Current report:
SEC Accession No. 0001736730-25-000092
Filing Date
2025-11-06
Accepted
2025-11-06 16:08:49
Documents
13
Period of Report
2025-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K camp-20251106.htm   iXBRL 8-K 26505
2 EX-99.1 exhibit991-camp4reportsthi.htm EX-99.1 69062
  Complete submission text file 0001736730-25-000092.txt   232076

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT camp-20251106.xsd EX-101.SCH 1770
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT camp-20251106_lab.xml EX-101.LAB 24358
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT camp-20251106_pre.xml EX-101.PRE 14111
15 EXTRACTED XBRL INSTANCE DOCUMENT camp-20251106_htm.xml XML 3038
Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Filer) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42365 | Film No.: 251458291
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)